Related content
© 2025 MJV Technology & Innovation. All rights reserved
Smart QCs: GSK’s Transformation Journey
MJV supported the pharmaceutical giant with a tailored change management strategy
GSK: Driving Integration Forward
Change doesn’t have to be complicated
The market is constantly pushing organizations to evolve.
MJV brings deep expertise in change management, helping teams stay engaged, mitigate risks, and boost efficiency.
Talk to a consultant and discover how we can support your transformation.
About MJV
MJV Technology & Innovation is a global consulting firm that leverages AI to drive business growth, foster innovation, and solve complex challenges for some of the world’s largest companies.
Business Innovation
Technology & Data
Design & Experience
Agile & Cultural Transformation
Sustainability & ESG Transformation
28+ years of experience
Presence in the US, Europe, and Latin America
A global team of 1,100+ experts: designers, engineers, anthropologists, data scientists, developers, and marketers
Our five business pillars are:
About MJV
MJV Technology & Innovation is a global consulting firm that leverages AI to drive business growth, foster innovation, and solve complex challenges for some of the world’s largest companies.
Agile & Cultural Transformation
Business Innovation
Technology & Data
Design & Experience
Sustainability & ESG Transformation
Our five business pillars are:
28+ years of experience.
Presence in the US, Europe, and Latin America.
A global team of 1,100+ experts: designers, engineers, anthropologists, data scientists, developers, and marketers.
Support GSK in its technological, operational, and cultural transformation with a global change management approach.
THE CHALLENGE
Strategy:
Global and Scalable
Change Management at GSK:
Industry: Pharmaceutical
Client : GlaxoSmithKline ( )
We don’t miss anything anymore—it’s easy to see everything now.
Things are clearer, more structured, and information flows better.
We handle unexpected events more easily now.
The “Go BIG” strategy accelerated the global rollout of Smart QC, delivering a strategic transformation through employee engagement, targeted communication, structured support, and clear governance frameworks.
Phases:
MJV Accelerates Global IA Adoption at GSK
people impacted
+900
10
labs around the globe
85
integrated teams
The mission was ambitious: unify nearly 100 teams across six languages.
To ensure success, MJV crafted a fully customized change management approach tailored to GSK’s specific needs.
Change Management at GSK:
How can you reduce the delivery time of a new vaccine? This question drove GlaxoSmithKline (GSK), a global pharmaceutical leader, to fully integrate its Quality Control (QC) operations.
The goal was crystal clear: modernize processes, implement a Smart QC approach, and accelerate the time-to-market for new vaccines. As part of this initiative, GSK rolled out an AI-driven platform to enhance management within its Vaccines Department.
MJV partnered with GSK to scale this operational transformation through a global change management strategy.
Smart QCs GSK: A Success Story
MJV played a key role in turning challenges into opportunities—driving digital transformation and positioning GSK as a benchmark in innovation and quality control.
The successful platform adoption led to major gains in productivity, data visibility, and faster decision-making.
See the results
10 laboratories
6 languages
6 languages supported during implementation
A global, scalable change management playbook
Significant productivity gains and improved visibility in QC processes
Deliverables:
Employee Engagement
Interactive workshops and feedback sessions helped surface team concerns and ensure active involvement in the transformation process.
Check the deliverables in each of these stages:
Tailored Communication
A cross-cultural communication campaign highlighted the tool’s benefits and positive day-to-day impact.
Training Materials
Standardized training content supported consistent process adoption across regions.
Governance & KPIs
Defined success metrics and a governance model allowed continuous monitoring and adjustment, aligning implementation with GSK’s strategic goals.
